Cyclophosphamide and Nitazoxanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cyclophosphamide (cyclophosphamide) and Nitazoxanide (nitazoxanide). Common drug interactions include aplastic anaemia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Cyclophosphamide and Nitazoxanide. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

What is Nitazoxanide?

Nitazoxanide has active ingredients of nitazoxanide. eHealthMe is studying from 286 Nitazoxanide users. Check the latest studies of Nitazoxanide.



On Jul, 19, 2026

33 people who take Cyclophosphamide and Nitazoxanide together, and have interactions are studied.

Cyclophosphamide and Nitazoxanide drug interactions.

What are the common drug interactions of Cyclophosphamide and Nitazoxanide, by gender? *:

female:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  3. Systemic candida (whole body fungal infection)
  4. Candida sepsis (candida in blood stream)
  5. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  6. Biliary tract infection bacterial (bacterial infections of the biliary tract)
  7. Drug ineffective
  8. Infective exacerbation of bronchiectasis (severe infective lung disease)
  9. Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
  10. Hepatic failure (liver failure)

male:

  1. Diarrhoea
  2. Disease progression
  3. Blood immunoglobulin a decreased
  4. Blood immunoglobulin g decreased
  5. Blood immunoglobulin m decreased
  6. Colitis (inflammation of colon)
  7. Cryptosporidiosis infection (an intestinal disease caused by the cryptosporidium parasite)
  8. Pneumonia
  9. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  10. Septic shock (shock due to blood infection)

What are the common drug interactions of Cyclophosphamide and Nitazoxanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  3. Systemic candida (whole body fungal infection)
  4. Candida sepsis (candida in blood stream)
  5. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  6. Biliary tract infection bacterial (bacterial infections of the biliary tract)
  7. Drug ineffective
  8. Infective exacerbation of bronchiectasis (severe infective lung disease)
  9. Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
  10. Hepatic failure (liver failure)

20-29:

n/a

30-39:

n/a

40-49:

  1. Cryptosporidiosis infection (an intestinal disease caused by the cryptosporidium parasite)
  2. Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
  3. Bk virus infection
  4. Cytomegalovirus infection
  5. Decreased appetite
  6. Diarrhoea
  7. Immunodeficiency
  8. Pneumonia fungal
  9. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  10. Sinusitis (inflammation of sinus)

50-59:

n/a

60+:

  1. Colitis (inflammation of colon)
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Parasitic gastroenteritis (inflammation of the digestive tract by parasite infection)
  4. Electrocardiogram qt prolonged
  5. Giardiasis (intestinal infection caused by the parasite giardia lamblia)
  6. Hypokalaemia (low potassium)
  7. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  8. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  9. Blood immunoglobulin a decreased
  10. Blood immunoglobulin g decreased

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 11 people, 33.33%
  2. Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 8 people, 24.24%
  3. Cryptosporidiosis Infection (an intestinal disease caused by the cryptosporidium parasite): 8 people, 24.24%
  4. Combined Immunodeficiency: 8 people, 24.24%
  5. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 15.15%
  6. Gastroenteritis Cryptosporidial (inflammation of stomach and intestine caused by cryptosporidial infection): 4 people, 12.12%
  7. Pneumonia Pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa): 3 people, 9.09%
  8. Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 9.09%
  9. Post Transplant Lymphoproliferative Disorder: 2 people, 6.06%
  10. Lymphoma (cancer that begins in immune system cells): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclophosphamide and Nitazoxanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cyclophosphamide and Nitazoxanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitazoxanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyclophosphamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitazoxanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cyclophosphamide and nitazoxanide (the active ingredients of Cyclophosphamide and Nitazoxanide, respectively), and Cyclophosphamide and Nitazoxanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: